Corporate DisclosureIBP
IBP Corporate Disclosure — 27 August 2019
Announcement summary
- What happened
- IBP published a corporate disclosure on 27 August 2019. Read the full announcement for details.
- Company
- Indo-Bangla Pharmaceuticals Limited
- Announcement published
Original announcement
The Company has informed that they have made a Manufacturing Agreement on August 26, 2019 with RHK GLOBAL (HK) LTD., Hong Kong, under which Super Tramex-100mg brand Tablet (Generic Name: Tramadol) will be produced in Indo-Bangla Pharmaceuticals Ltd.?s production plant, College road, Barisal, Bangladesh. As per the Agreement they will produce 1200 million Tablet/p.a. and the revenue of which is projected to be BDT 600 mn /p.a.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aceb25a6b00004005924c
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from IBP
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.